Exonova Biosciences LLC

Exonova Biosciences LLC is a woman-owned small business sole proprietorship based in Bethesda, Maryland, that provides specialized scientific support services to the federal government. The company registered with SAM.gov in September 2023 and maintains active federal contracting status through June 2026. Exonova Biosciences operates in the biomedical research sector, delivering laboratory-based and scientific consulting services with particular expertise in inflammatory and vascular disease research, immunology, and advanced cellular and molecular biology methodologies.

Exonova Biosciences has established a consistent contracting relationship with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) through a series of annual purchase order awards totaling $550,000 over a three-year period from 2024 through 2026. The company has served as a prime contractor on three separate awards: a $180,000 contract for calendar year 2024, a $180,000 contract for calendar year 2025, and a $190,000 contract for calendar year 2026, with the most recent award issued on January 1, 2026. These contracts require the contractor to provide services from PhD-level scientists with over 15 years of specialized experience in immunology and inflammation research. The technical scope of work encompasses laboratory-based patient sample testing services, molecular cloning, exosome isolation and engineering, microRNA analysis and transfection, induced pluripotent stem cell (iPSC) processing, and single-cell RNA sequencing. All three awards were structured as firm fixed-price purchase orders without set-aside designations, with work performed at NIDDK facilities in Bethesda, Maryland, supporting the agency's Biomedical and Metabolic Imaging Branch in advancing research on metabolic diseases and kidney health.